The global drug screening market is projected to grow from USD 10.55 billion in 2025 to USD 39.32 billion by 2034, registering a CAGR of 15.79%. The surge is fueled by rising drug abuse, strict regulatory mandates, technological advancements in screening tools, and increased implementation across workplaces, healthcare, and forensic sectors.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Drug Screening Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Drug Screening Market Revenue and Volume, by Product And Service
8.1.1 Drug Screening Product
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Analytical Instruments
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Rapid Testing Devices
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Oral Fluid Testing Devices
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Consumables
8.1.5.1. Market Revenue and Volume Forecast
8.1.6. Drug Screening Service
8.1.6.1. Market Revenue and Volume Forecast
9.1. Drug Screening Market Revenue and Volume, by Sample Type
9.1.1. Urine Sample
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Breath Sample
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Oral Fluid Sample
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Hair Sample
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Others Sample
9.1.5.1. Market Revenue and Volume Forecast
10.1. Drug Screening Market Revenue and Volume, by End-user
10.1.1. Drug Testing Labs
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Workplaces
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Criminal Justice and Law Enforcements Agencies
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Hospitals
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Drug Treatment Centre
10.1.5.1. Market Revenue and Volume Forecast
10.1.6. Individual Users
10.1.6.1. Market Revenue and Volume Forecast
10.1.7. Pain Management Centre
10.1.7.1. Market Revenue and Volume Forecast
10.1.8. Schools And Colleges
10.1.8.1. Market Revenue and Volume Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Product And Service
11.1.2. Market Revenue and Volume Forecast, by Sample Type
11.1.3. Market Revenue and Volume Forecast, by End-user
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Product And Service
11.1.4.2. Market Revenue and Volume Forecast, by Sample Type
11.1.4.3. Market Revenue and Volume Forecast, by End-user
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Product And Service
11.1.5.2. Market Revenue and Volume Forecast, by Sample Type
11.1.5.3. Market Revenue and Volume Forecast, by End-user
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Product And Service
11.2.2. Market Revenue and Volume Forecast, by Sample Type
11.2.3. Market Revenue and Volume Forecast, by End-user
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Product And Service
11.2.4.2. Market Revenue and Volume Forecast, by Sample Type
11.2.4.3. Market Revenue and Volume Forecast, by End-user
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Product And Service
11.2.5.2. Market Revenue and Volume Forecast, by Sample Type
11.2.5.3. Market Revenue and Volume Forecast, by End-user
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Product And Service
11.2.6.2. Market Revenue and Volume Forecast, by Sample Type
11.2.6.3. Market Revenue and Volume Forecast, by End-user
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Product And Service
11.2.7.2. Market Revenue and Volume Forecast, by Sample Type
11.2.7.3. Market Revenue and Volume Forecast, by End-user
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Product And Service
11.3.2. Market Revenue and Volume Forecast, by Sample Type
11.3.3. Market Revenue and Volume Forecast, by End-user
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Product And Service
11.3.4.2. Market Revenue and Volume Forecast, by Sample Type
11.3.4.3. Market Revenue and Volume Forecast, by End-user
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Product And Service
11.3.5.2. Market Revenue and Volume Forecast, by Sample Type
11.3.5.3. Market Revenue and Volume Forecast, by End-user
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Product And Service
11.3.6.2. Market Revenue and Volume Forecast, by Sample Type
11.3.6.3. Market Revenue and Volume Forecast, by End-user
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Product And Service
11.3.7.2. Market Revenue and Volume Forecast, by Sample Type
11.3.7.3. Market Revenue and Volume Forecast, by End-user
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Product And Service
11.4.2. Market Revenue and Volume Forecast, by Sample Type
11.4.3. Market Revenue and Volume Forecast, by End-user
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Product And Service
11.4.4.2. Market Revenue and Volume Forecast, by Sample Type
11.4.4.3. Market Revenue and Volume Forecast, by End-user
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Product And Service
11.4.5.2. Market Revenue and Volume Forecast, by Sample Type
11.4.5.3. Market Revenue and Volume Forecast, by End-user
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Product And Service
11.4.6.2. Market Revenue and Volume Forecast, by Sample Type
11.4.6.3. Market Revenue and Volume Forecast, by End-user
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Product And Service
11.4.7.2. Market Revenue and Volume Forecast, by Sample Type
11.4.7.3. Market Revenue and Volume Forecast, by End-user
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Product And Service
11.5.2. Market Revenue and Volume Forecast, by Sample Type
11.5.3. Market Revenue and Volume Forecast, by End-user
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Product And Service
11.5.4.2. Market Revenue and Volume Forecast, by Sample Type
11.5.4.3. Market Revenue and Volume Forecast, by End-user
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Product And Service
11.5.5.2. Market Revenue and Volume Forecast, by Sample Type
11.5.5.3. Market Revenue and Volume Forecast, by End-user
12.1. Quest Diagnostics Incorporated
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Abbott Laboratories
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Quidel Corporation
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. F. Hoffmann-La Roche
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Thermo Fisher Scientific, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Siemens Healthineers
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Bio-Rad Laboratories, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Agilent Technologies, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. LabCorp
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Drgerwerk AG & CO. KGaA
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description